HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase I study of ICRF-159 (NSC-129943) in human solid tumors.

AuthorsR E Bellet, M J Mastrangelo, L M Dixon, J W Yarbro
JournalCancer chemotherapy reports (Cancer Chemother Rep) Vol. 57 Issue 2 Pg. 185-9 (Apr 1973) ISSN: 0069-0112 [Print] United States
PMID4742498 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Hemoglobins
  • Piperazines
  • Propane
Topics
  • Aged
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Carcinoma (blood, drug therapy)
  • Female
  • Hemoglobins (metabolism)
  • Humans
  • Leukocyte Count
  • Lung Neoplasms (blood, drug therapy)
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Piperazines (adverse effects, therapeutic use)
  • Propane (adverse effects, therapeutic use)
  • Reticulocytes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: